Ambar Protein Industries reports FY26 net profit of ₹702.66 lakh
Ambar Protein Industries Limited reported a net profit of ₹702.66 lakh for FY26, with revenue from operations rising to ₹50,065.59 lakh. The Board approved the audited standalone financial results for the quarter and year ended March 31, 2026, and re-appointed Rajendra Natverlal Shah & Co. as internal auditor. The statutory auditor issued an unmodified opinion on the results.

*this image is generated using AI for illustrative purposes only.
Ambar Protein Industries Limited reported a net profit of ₹702.66 lakh for the financial year ended March 31, 2026, while revenue from operations increased to ₹50,065.59 lakh. The company's Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, during a meeting held on May 30, 2026. The statutory auditor, M/s. Fenil P Shah and Associates, issued an audit report with an unmodified opinion on the standalone financial results.
For the quarter ended March 31, 2026, the company recorded a net profit of ₹246.41 lakh on revenue from operations of ₹14,679.97 lakh. Total income for the quarter stood at ₹14,701.83 lakh, while total expenses were ₹14,358.80 lakh. The basic and diluted earnings per share (EPS) for the quarter were reported at ₹4.29 each.
The full-year financial performance showed a total income of ₹50,143.72 lakh against total expenses of ₹49,205.13 lakh. The profit before tax for the year was ₹938.59 lakh, with a total tax expense of ₹235.93 lakh. Basic and diluted EPS for the year were ₹12.22. The company's only business segment is the manufacturing and selling of edible oil.
Financial Results for FY26
| Particulars | Year Ended 31.03.2026 (₹ in Lacs) | Year Ended 31.03.2025 (₹ in Lacs) |
|---|---|---|
| Revenue from operations | 50,065.59 | 42,162.30 |
| Total Income | 50,143.72 | 42,246.46 |
| Total Expenses | 49,205.13 | 40,943.36 |
| Profit before tax | 938.59 | 1,303.11 |
| Net Profit | 702.66 | 965.02 |
| Basic EPS (₹) | 12.22 | 16.78 |
Board Decisions
The Board approved the re-appointment of Rajendra Natverlal Shah & Co. as the internal auditor for FY 2026-27. Additionally, the Board approved related party transactions with Ankur Oil Industries regarding the sale of goods and job work, subject to shareholder approval. The company confirmed that the financial results were prepared in accordance with Indian Accounting Standards (Ind AS) and reviewed by the Audit Committee.
Pursuant to Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the company submitted newspaper clippings of the audited standalone financial results for the quarter and year ended March 31, 2026. The results were published in English and Gujarati newspapers on June 02, 2026.
Historical Stock Returns for Ambar Protein Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -5.47% | -7.24% | -33.24% | -28.92% | +2,297.96% |
What strategies will Ambar Protein Industries implement to reverse the decline in net profit and EPS compared to the previous fiscal year?
How will the approved related party transactions with Ankur Oil Industries impact the company's operational margins in FY 2026-27?
What are the company's capital expenditure plans for the upcoming year to support the growth in revenue from operations?

































